Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $69.22M in the quarter ending March 31, 2024, with 119.07% growth. This brings the company's revenue in the last twelve months to $224.00M, up 133.90% year-over-year. In the year 2023, Mirum Pharmaceuticals had annual revenue of $186.37M with 141.85% growth.

• Revenue (ttm): $224.00M
• Revenue Growth: +133.90%
• P/S Ratio: 8.41
• Revenue / Employee: $848,477
• Employees: 264
• Market Cap: 2.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	186.37M	109.31M	141.85%
Dec 31, 2022	77.06M	57.92M	302.66%
Dec 31, 2021	19.14M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.